Scott, David A., Loveman, E., McIntyre, Linda and Waugh, Norman. (2002) Screening for gestational diabetes : a systematic review and economic evaluation. Health Technology Assessment, Vol.6 (No.11). ISSN 1366-5278

Preview	Text WRAP_Waugh_GDMmon.pdf - Published Version Download (757Kb) | Preview
Preview	Text (Cover sheet) WRAP_waugh17_Coversheet_FinalVersion.pdf Download (167Kb) | Preview

Abstract

Background Screening for gestational diabetes mellitus (GDM) has been controversial, with some expert bodies advising universal screening, others selective screening, and yet others advising against screening at all. This has partly been a result of debate about the definition of GDM, and partly because of the profusion of different tests available, both for screening and definite diagnosis. In the UK, there is no national policy on screening, and a variety of practices exist in different parts of the country. There have also been doubts about the treatment of GDM, and particularly about management of minor degrees of glucose elevation, which are better described as glucose intolerance rather than true diabetes. Objectives To provide an updated review of current knowledge, to clarify research needs, and to assist with policy making in the interim, pending future research. Methods A literature review was carried out, with a particular focus on screening methods and costs, and an appraisal of screening for GDM against the criteria for assessing screening programmes used by the UK National Screening Committee (NSC). Results There is still debate about what is meant by GDM – the threshold for diagnosis is not soundly based; the terms GDM and impaired glucose tolerance are not used in a standard fashion in pregnancy; there is almost certainly a continuum of risk to the baby, rather than there being separate normal and abnormal groups; and the key risk factor in most women may be maternal overweight, with glucose intolerance being an associate of that. In addition there are some rare genetic conditions, which affect a few women, such as glucokinase and hepatic nuclear factor disorders. GDM is usually defined according to divergence from normal glucose levels, but glucose levels are usually raised in pregnancy, and so diagnosis by normal levels in non-pregnant women may misclassify many normal pregnant women as abnormal. This may lead to anxiety and the inconvenience of extra investigations and ‘disease’ care. The Caesarean section rate appears to be increased by the diagnosis alone. Ideally, the condition should be defined by the incidence of adverse effects. However, the most common reported complication of GDM is ‘macrosomia’ in the baby. This is usually defined by arbitrary weight cut-offs (usually a birth weight of 4000 g, but sometimes 4500 g), but such neat thresholds fail to distinguish between larger than average healthy babies and those that have the abnormal growth patterns associated with high insulin levels in the womb. Screening for GDM fails to meet some of the NSC criteria. A number of screening tests have been used but some, such as glycosylated haemoglobin and fructosamine, have proved unsatisfactory and can be discarded. Others, such as urine testing or random blood glucose, are far from satisfactory, although they may be cheap to do. There is marked international variation. Risk factors such as weight, age and family history are useful for selective screening but some patients with GDM would be missed. Fasting plasma glucose (FPG) is convenient and reliable, but some pregnant women have normal fasting levels but raised levels of glucose after meals, and would be missed by screening based on FPG alone. Glucose challenge tests (GCTs) are based on glucose levels after a glucose drink, but also have shortcomings. The definitive diagnosis is usually by oral glucose tolerance test (OGTT), but the glucose load and timing vary in different countries; taking a 75 g glucose load is unnatural, makes some women sick, and the reproducibility of the test is poor. More natural methods such as test meals have been used, but not widely. Conclusions Interim conclusions There are clearly some women whose glucose levels rise sufficiently in pregnancy to cause harm to their babies. However, there are also many women with lower levels of glucose intolerance whose babies are not at risk, but who may suffer anxiety and inconvenience as a result of being classed as abnormal. On balance, the present evidence suggests that we should not have universal screening, but a highly selective policy, based on age and overweight. The best test at present, for those deemed to need testing, is probably the GCT, preferably combined with an FPG. The benefits of a follow-up OGTT are doubtful.

Item Type:	Journal Article
Subjects:	R Medicine > RA Public aspects of medicine
Divisions:	Faculty of Medicine > Warwick Medical School > Health Sciences
Library of Congress Subject Headings (LCSH):	Diabetes in pregnancy -- Diagnosis, Medical screening
Journal or Publication Title:	Health Technology Assessment
Publisher:	National Coordinating Centre for Health Technology Assessment
ISSN:	1366-5278
Date:	2002
Volume:	Vol.6
Number:	No.11
Status:	Peer Reviewed
Publication Status:	Published
Funder:	NIHR Health Technology Assessment Programme (Great Britain)
References:	1. Mires GJ, Williams FLR, Harper V. Screening practices for gestational diabetes mellitus in UK obstetric units. Diabet Med 1999;16:138–41. 2. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183–7. 3. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 1998;21 Suppl 1. 4. Coustan DR, Nelson C, Carpenter MW, Carr SR, Rotondo L, Widness JA. Maternal age and screening for gestational diabetes: a populationbased study. Obstet Gynecol 1989;73:557–61. 5. US Preventive Services Task Force. Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force, 2nd edn. Baltimore, USA: Williams and Wilkins; 1996. p. 193–208. 6. Canadian Task Force on the Periodic Health Examination. The periodic health examination, 1992 update: 1. Screening for gestational diabetes mellitus. Can Med Assoc J 1992;147:435–43. 7. Thompson DM, Wylie B, Bryer-Ash M, Creed M, Jenkins L, Kozak S, et al. Gestational diabetes: to screen or not to screen [letter]. Can Med Assoc J 1993;148:13. 8. Ryan EA. To screen or not to screen? [letter]. Can Med Assoc J 1993;148:11. 9. Jarrett RJ. Should we screen for gestational diabetes? The concept of gestational diabetes was popularised before considerations of evidence based medicine came on the scene. BMJ 1997;315:736–7. 10. Stephenson MJ. Screening for gestational diabetes mellitus: a critical review. J Fam Pract 1993;37:277–83. 11. Goer H. Gestational diabetes: the emperor has no clothes. Birth Gazette 1996;12:32–5. 12. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol 1991;44:1271–8. 13. Dornhorst A, Beard RW. Gestational diabetes: a challenge for the future. Diabet Med 1993;10:897–905. 14. Dornhorst A, Chan SP. The elusive diagnosis of gestational diabetes. Diabet Med 1998;15:7–10. 15. Griffiths M. Debate over screening for gestational diabetes. BMJ 1998;316:861. 16. Ray J. Debate over screening for gestational diabetes – evidence from randomised controlled trial is needed. BMJ 1998;316:861. 17. American Diabetes Association. Position statement on gestational diabetes mellitus. Diabetes Care 1989;9:430–1. 18. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039–57. 19. O’Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964;13:278–85. 20. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768–73. 21. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998;21 Suppl 2:16–17. 22. Naylor CD, Sermer M, Chen E, Sykora K. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto Trihospital Gestational Diabetes Investigators. JAMA 1996;275:1165–70. 23. Nord E, Hanson U, Persson B. Blood glucose limits in the diagnosis of impaired glucose tolerance during pregnancy. Acta Obstet Gynecol Scand 1995;74:589–93. 24. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Med 1998;15:539–53. 25. Schmidt MI, Matos MCG, Reichelt AJ, Costa Forti A, de Limas L, Duncan BB. Prevalence of gestational diabetes mellitus – do the new WHO criteria make a difference? Brazilian Gestational Diabetes Study Group. Diabetic Med 2000;17:376–80. 26. Weiss PAM, Haeusler MCH, Kainer F, Purstner P, Haas J. Towards universal criteria for gestational diabetes: relationships between 75 and 100 g glucose loads and between capillary and venous glucose concentrations. Am J Obstet Gynecol 1998;178:830–5. 27. Martin FIR. The diagnosis of gestational diabetes. Med J Aust 1991;155:112. 28. Oats JN, Beischer NA. Gestational diabetes. Aust N Z J Obstet Gynaecol 1986;26:2–10. 29. Dornhorst A, Hadden D. Diabetes and pregnancy: an international approach to diagnosis and management. Chichester: John Wiley & Sons; 1996. 30. Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med 1999;341:1749–56. 31. Sermer M, Naylor CD, Gare DJ, Kenshole AB, Ritchie JW, Farine D, et al. Impact of time since last meal on the gestational glucose challenge test. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1994;171:607–16. 32. Essel JK, Opai-Tetteh ET. Macrosomia – maternal and fetal risk factors. S Afr Med J 1995;85:43–6. 33. Spellacy WN, Miller S, Winegar A, Peterson PQ. Macrosomia – maternal characteristics and infant complications. Obstet Gynecol 1985;66:158–61. 34. Weiss PAM, Haeusler MCH, Tamussino K, Haas J. Can glucose tolerance test predict fetal hyperinsulinism? Br J Obstet Gynaecol 2000;107:1480–5. 35. Stanley KP, Fraser RB. Cord insulin and C-peptide – distribution in an unselected population. Br J Obstet Gynaecol 1992;99:512–15. 36. Ales KL, Santini DL. Should all pregnant women be screened for gestational glucose intolerance? Lancet 1989;i:1187–91. 37. Modanlou HD, Komatsu G, Dorchester W, Freeman RK, Bosv SK. Large for gestational age neonates: anthropometric reasons for shoulder dystocia. Obstet Gynecol 1982;60:417–23. 38. Sacks DA. Fetal macrosomia and gestational diabetes: what’s the problem? Obstet Gynecol 1993;81:775–81. 39. Sharp PS, O’Connor R, Young S, Wooton J, Frost P. Gestational diabetes mellitus. BMJ 1993;306:581. 40. Hammami M, Walters JC, Hockman EM, Koo WW. Disproportionate alterations in body composition of large for gestational age neonates. J Pediatr 2001;138:817–21. 41. Schwartz R, Teramo KA. What is the significance of macrosomia? Diabetes Care 1999;22:1201–5. 42. Potter EL, Craig JM, editors. Pathology of the fetus and the infant. Chicago: Year Book, Medical Publishers Inc.; 1975. 43. Fraser RB, Bruce C. Amniotic fluid insulin levels identify the fetus at risk of neonatal hypoglycaemia. Diabet Med 1999;16:568–72. 44. Jensen DM, Sorensen B, Feilberg-Jorgensen N, Westergaard JG, Beck-Nielsen H. Maternal and perinatal outcomes in 143 Danish women with gestational diabetes mellitus and 143 controls with a similar risk profile. Diabet Med 2000;17:281–6. 45. Nasrat HA, Augensen K, Abushal M, Shalhoub JT. The outcome of pregnancy following untreated impaired glucose tolerance. Int J Gynaecol Obstet 1994;47:1–6. 46. Nordlander E, Hanson U, Persson B. Factors influencing neonatal morbidity in gestational diabetic pregnancy. Br J Obstet Gynaecol 1989;96:671–8. 47. Agardh CD, Aberg A, Norden NE. Glucose levels and insulin secretion during a 75 g glucose challenge test in normal pregnancy. J Intern Med 1996;240:303–9. 48. Hunter DJS, Keirse MJNC. Gestational diabetes. In: Chalmers I, Enkin M, Keirse MJNC, editors. Effective care in pregnancy and childbirth. Oxford: Oxford University Press; 1989. p. 403–10. 49. Langer O, Anyaegbunam A, Brustman L, Dixon M. Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol 1989;161:593–9. 50. Naylor CD. Diagnosing gestational diabetes mellitus: is the gold standard valid? Diabetes Care 1989;12:565–72. 51. Green JR, Schumacher LB, Pawson IG, Partridge JC, Kretchmer N. Influence of maternal body habitus and glucose tolerance on birth weight. Obstet Gynecol 1991;78:225–40. 52. Wilson J, Junger G. Principles and practice of screening for disease. WHO Public Health Paper 34. Geneva: WHO; 1968. 53. The UK National Screening Committee’s criteria for appraising the viability, effectiveness and appropriateness of a screening programme. 2001. URL: http://www.nsc.nhs.uk 54. NHS Centre for Reviews and Dissemination. The prevention and treatment of obesity. Effective Health Care 1997;3. 55. Edwards LE, Hellerstedt WL, Alton IR, Story M, Himes JH. Pregnancy complications and birth outcomes in obese and normal-weight women: effects of gestational weight change. Obstet Gynecol 1996;87:389–94. 56. Newman RB, Calhoun BC, Maganna E. Seasonal effects on the rate of fetal macrosomia. Am J Obstet Gynecol 1999;180:S35. 57. Lao TT, Lee CP. Gestational ‘impaired glucose tolerance’: should the cut-off be raised to 9 mmol l–1? Diabet Med 1998;15:25–9. 58. Pettitt DJ, Narayan KM, Hanson RL, Knowler WC. Incidence of diabetes mellitus in women following impaired glucose tolerance in pregnancy is lower than following impaired glucose tolerance in the non-pregnant state. Diabetologia 1996;39:1334. 59. Roberts RN, McManus J, Dobbs S, Hadden D. A standardised breakfast tolerance test in pregnancy: comparison with the 75 g oral glucose tolerance test in unselected mothers and in those with impaired glucose tolerance. Ulster Med J 1997;66:18–23. 60. Martin FIR, Ratnaike S, Wootton A, Condos P, Sutter PEN. The 75 g oral glucose tolerance test in pregnancy. Diabetes Res Clin Pract 1995;27:147–51. 61. Nasrat HA, Johnstone FD, Hasan SAM. Is random plasma glucose an efficient screening test for abnormal glucose tolerance in pregnancy? Br J Obstet Gynaecol 1988;95:855–60. 62. Hatem M, Anthony F, Hogston P, Rowe DJF, Dennis KJ. Reference values for 75 g glucose tolerance test in pregnancy. BMJ 1988;296:676–8. 63. Sutherland HW, Pearson DWM, Lean MEJ, Campbell DM. Breakfast tolerance test in pregnancy. In: Sutherland HW, Stowers JM, Pearson DWM, editors. Carbohydrate metabolism in pregnancy and the newborn IV. London: Springer-Verlag; 1989. p. 267–75. 64. Li DFH, Wong VCW, O’Hoy KM, Ma HK. Evaluation of the WHO criteria for the 75 g oral glucose tolerance test in pregnancy. Br J Obstet Gynaecol 1987;94:847–50. 65. Walkinshaw SA. Dietary regulation for ‘gestational diabetes’ (Cochrane Review). In: The Cochrane Library. Issue 3. Oxford: Update Software; 2000. 66. Fraser R. Diabetic control in pregnancy and intrauterine growth of the fetus. Br J Obstet Gynaecol 1995;102:275–7. 67. Persson B, Stangenberg M, Hansson U, Nordlander E. Gestational Diabetes Mellitus (GDM): comparative evaluation of two treatment regimens, diet versus insulin and diet. Diabetes 1985;34:101–4. 68. Simmons D, Robertson S. Influence of maternal insulin treatment on the infants of women with gestational diabetes. Diabet Med 1997;14:762–5. 69. Langer O, Rodriguez DA, Xenakis EM, McFarland KF, Berkus MD, Arredondo F. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol 1994;170:1036–47. 70. Buchanan TA, Kjos SL, Montoro MN, Wu HP, Madrilejo NG, Gonzalez M, et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994;17:275–83. 71. Bochner CJ, Medearis AL, Williams J, Castro L, Hobel CJ, Wade ME. Early third-trimester ultrasound screening in gestational diabetes to determine the risk of macrosomia and labor dystocia at term. Am J Obstet Gynecol 1987;157:703–8. 72. Johnstone FD, Prescott RJ, Steel JM, Mao JH, Chambers S, Muir N. Clinical and ultrasound prediction of macrosomia in diabetic pregnancy. Br J Obstet Gynaecol 1996;103:747–54. 73. Fraser RB, Ford FA, Lawrence GF. Insulin sensitivity in third trimester pregnancy. A randomised study of dietary effects. Br J Obstet Gynaecol 1988;95:223–9. 74. Langer O, Conway DL, Berkus MD, Xenakis EM-J, Gonzales O. Glyburide was as safe and effective as insulin in gestational diabetes. N Engl J Med 2000;343:1134–8. 75. Goldberg JD, Franklin B, Lasser D, Jornsay DL, Hausknecht RU, Ginsberg-Fellner F, et al. Gestational diabetes: impact of home glucose monitoring on neonatal birth weight. Am J Obstet Gynecol 1986;154:546–50. 76. Rey E. Screening for gestational diabetes mellitus. A simple test may make it easier to study whether screening is worthwhile. BMJ 1999;319:798–9. 77. Bung P, Artal R, Khodiguian N, Kjos SL. Exercise in gestational diabetes. An optional therapeutic approach? Diabetes 1991;40:182–5. 78. Jovanovic-Peterson L, Peterson CM. Review of gestational diabetes mellitus and low-calorie diet and physical exercise as therapy. Diabetes Metab Rev 1996;12:287–308. 79. Avery MD, Leon AS, Kopher RA. Effects of a partially home-based exercise program for women with gestational diabetes. Obstet Gynecol 1997;89:10–15. 80. Lesser KB, Gruppuso PA, Terry RB, Carpenter M. Exercise fails to improve postprandial glycemic excursion in women with gestational diabetes. J Matern Fet Med 1996;5:211–17. 81. Dye TD, Knox KL, Artal R, Aubry RH, Wojtowycz MA. Physical activity, obesity, and diabetes during pregnancy. Am J Epidemiol 1997;146:961–5. 82. Stowers JM, Sutherland HW, Kerridge DF. Longrange implications for the mother: the Aberdeen experience. Diabetes 1985;34:106–10. 83. Wein P, Beischer NA, Sheedy MT. Studies of postnatal diabetes mellitus in women who had gestational diabetes. Part II. Prevalence and predictors of diabetes mellitus after delivery. Aust N Z J Obstet Gynaecol 1997;37:420–3. 84. Gregory K, Kjos SL, Peters RK. Cost of non insulin dependent diabetes in women with a history of gestational diabetes: implications for prevention. Obstet Gynecol 1993;81:782–6. 85. Langer O, Levy JC, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus – how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol 1989;161:646–53. 86. Wen SW, Liu S, Kramer MS, Joseph KS, Levitt C, Marcoux S, et al. Impact of prenatal glucose screening on the diagnosis of gestational diabetes and on pregnancy outcomes. Am J Epidemiol 2000;152:1009–14. 87. Moses RG. Gestational diabetes: is a higher Cesarean section rate inevitable? Diabetes Care 2000;23:15–17. 88. Santini DL, Ales KL. The impact of universal screening for gestational glucose intolerance on outcome of pregnancy. Surg Gynecol Obstet 1990;170:427–36. 89. Sacks DA, Abu FS, Karten GJ, Forsythe AB, Hackett JR. Screening for gestational diabetes with the one-hour 50-g glucose test. Obstet Gynecol 1987;70:89–93. 90. Rouse DJ, Owen J, Goldenberg RL, Cliver SP. The effectiveness and costs of elective caesarean delivery for fetal macrosomia diagnosed by ultrasound. JAMA 1996;276:1480–6. 91. Roversi GD, Gargiulo M, Nicolini U, Pedretti E, Marini A, Barbarani V, et al. A new approach to the treatment of diabetic pregnant women. Am J Obstet Gynecol 1979;135:567–76. 92. Stenninger E, Schollin J, Aman J. Early postnatal hypoglycaemia in newborn infants of diabetic mothers. Acta Paediatr 1997;86:1374–6. 93. Owen J, Phelan ST, Landon MB, Gabbe SG. Gestational diabetes survey. Am J Obstet Gynecol 1995;172:615–20. 94. Magee MS, Walden CE, Benedetti TJ, Knopp RH. Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity. JAMA 1993;269:609–15. 95. Khine ML, Winklestein A, Copel JA. Selective screening for gestational diabetes mellitus in adolescent pregnancies. Obstet Gynecol 1999;93:738–42. 96. Mello G, Parretti E, Mecacci F, Lucchetti R, Lagazio C, Pratesi M, et al. Risk factors for fetal macrosomia: the importance of a positive oral glucose challenge test. Eur J Endocrinol 1997;137:27–33. 97. Schwartz JG, Phillips WT, Blumhardt MR, Langer O. Use of a more physiologic oral glucose solution during screening for gestational diabetes mellitus. Am J Obstet Gynecol 1994;171:685–91. 98. Tardioli MC, Massi Benedetti M, Angeli G, Damiani F, Frascarelli A, Gigliarelli D, et al. A pilot study for the screening of gestational diabetes mellitus. Diabetes Nutr Metab 1993;6:377–80. 99. Berkowitz GS, Roman SH, Lapinski RH, Alvarez M. Maternal characteristics, neonatal outcome, and the time of diagnosis of gestational diabetes. Am J Obstet Gynecol 1992;167:976–82. 100. O’Sullivan JB, Mahan CM, Charles D, Danrow RV. Screening criteria for high risk gestational diabetic patients. Am J Obstet Gynecol 1973;116:895–900. 101. Bobrowski RA, Bottoms SF, Micallef JA, Dombrowski MP. Is the 50-gram glucose screening test ever diagnostic? J Matern Fetal Med 1996;5:317–20. 102. Corrado F, Stella NC, Mancuso A, Triolo O, Bruno L, Artenisio AC. Screening for gestational diabetes in Sicily. J Reprod Med Obstet Gynecol 1999;44:875–8. 103. Hong PL, Benjamin F, Deutsch S. First prenatal visit glucose screening. Am J Perinatol 1989;6:433–6. 104. Perucchini D, Fischer U, Spinas GA, Huch R, Huch A, Lehmann R. Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study. BMJ 1999;319:812–15. 105. Harlass FE, Brady K, Read JA. Reproducibility of the oral glucose tolerance test in pregnancy. Am J Obstet Gynecol 1991;164:564–8. 106. Neiger R, Coustan DR. The role of repeat glucose tolerance tests in the diagnosis of gestational diabetes. Am J Obstet Gynecol 1991;165:787–90. 107. Fachnie JD, Whitehouse FW, McGrath Z. Vomiting during OGTT in third trimester pregnancy. Diabetes Care 1988;11:18. 108. WHO Expert Committee on Diabetes Mellitus. Technical Report Series 646. Geneva: World Health Organization; 1980. 109. Kvetny J, Poulsen HF, Damgaard DW. Results from screening for gestational diabetes mellitus in a Danish county. Dan Med Bull 1999;46:57–9. 110. Deerochanawong C, Putiyanun C, Wongsuryrat M, Serirat S, Jinayon P. Comparison of National Diabetes Data Group and World Health Organization criteria for detecting gestational diabetes mellitus. Diabetologia 1996;39:1070–3. 111. Hanson U, Kallner A. Oral glucose tolerance test in pregnancy. Evaluation of a simplified procedure. Acta Obstet Gynecol Scand 1984;63:249–52. 112. Landy HJ, Gomez MO, O’Sullivan MJ. Diagnosing gestational diabetes mellitus: use of a glucose screen without administering the glucose tolerance test. Obstet Gynecol 1996;87:395–400. 113. Nelson-Piercy C, Gale EAM. Do we know how to screen for gestational diabetes – current practice in one regional health authority. Diabet Med 1994;11:493–8. 114. Chiaffarino F, Parazzini F, Bortolotti A, Benzi G. Scientific uncertainty is mirrored in clinical practice in Italy. BMJ 1998;316:861. 115. Dornhorst A, Paterson CM, Nicholls JSD, Wadsworth J, Chiu DC, Elkeles RS, et al. High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med 1992;9:820–5. 116. Marquette GP, Klein VR, Niebyl JR. Efficacy of screening for gestational diabetes. Am J Perinatol 1985;2:7–9. 117. Helton MR, Arndt J, Kebede M, King M. Do low-risk prenatal patients really need a screening glucose challenge test? J Fam Pract 1997;44:556–61. 118. Weeks JW, Major CA, de Veciana M, Morgan MA. Gestational diabetes: does the presence of risk factors influence perinatal outcome? Am J Obstet Gynecol 1994;171:1003–7. 119. Moses RG, Griffiths R, Davies W. Gestational diabetes: do all women need to be tested? Aust N Z J Obstet Gynaecol 1995;35:387–9. 120. Coustan DR. Methods of screening for and diagnosing of gestational diabetes. Clin Perinatol 1993;20:593–602. 121. Rodriguez H, Neiger R, Thompson S, List M, Krohn H. Screening adolescent gravidas for gestational diabetes. Adolesc Pediatr Gynecol 1995;8:125–7. 122. Truscello AM, Hollingsworth DR, Felice ME, Shragg P. Routine screening for gestational diabetes in white, black, and Mexican–American teenagers. J Adolesc Health Care 1988;9:150–5. 123. Court DJ, Mann SL, Stone PR, Goldsbury SM, Dixon-McIvor D, Baker JR. Comparison of glucose polymer and glucose for screening and tolerance tests in pregnancy. Obstet Gynecol 1985;66:491–9. 124. Marquette GP, Klein VR, Repke JT, Niebyl JR. Costeffective criteria for glucose screening. Obstet Gynecol 1985;66:181–4. 125. Soltani H, Bruce C, Fraser RB. Observational study of maternal anthropometry and fetal insulin. Arch Dis Child Fetal Neonatal Ed 1999;81:F122–4. 126. Jimenez-Moleon JJ, Bueno-Cavanillas A, Luna-del- Castillo JD, Lardelli-Claret P, Garcia-Martin M, Galvez-Vargas R. Predictive value of a screen for gestational diabetes mellitus: influence of associated risk factors. Acta Obstet Gynecol Scand 2000;79:991–8. 127. Davey RX, Hamblin PS. Selective versus universal screening for gestational diabetes mellitus: an evaluation of predictive risk factors. Med J Aust 2001;174:118–21. 128. Onyeije CI, Divon M. Can early gestational weight gain predict macrosomia in pregnancies complicated by GDM? Am J Obstet Gynecol 1999;180:S40. 129. Branchtein L, Schmidt MI, Mengue SS, Reichelt AJ, Matos MCG, Duncan BB. Waist circumference and waist-to-hip ratio are related to gestational glucose tolerance. Diabetes Care 1997;20:509–11. 130. Newman RB. Maternal BMI can help determine which women need screening for GD [abstract]. Am J Obstet Gynecol 1999;180:S35. 131. Bundred P, Kitchiner D, Buchan I. Prevalence of overweight and obese children between 1989 and 1998: population based series of cross sectional studies. BMJ 2001;322:326–8. 132. Ford FA, Bruce C, Fraser RB. Fetal macrosomia in potential diabetics with normal oral glucose tolerance: a case control study. Br J Obstet Gynaecol 1990;97:957–9. 133. Gribble RK, Meier PR, Berg RL. The value of urine screening for glucose at each prenatal visit. Obstet Gynecol 1995;86:405–10. 134. Hooper DE. Detecting GD and preeclampsia. Effectiveness of routine urine screening for glucose and protein. J Reprod Med 1996;41:885–8. 135. Watson WJ. Screening for glycosuria during pregnancy. South Med J 1990;83:156–8. 136. Lind T, Hytten FM. The excretion of glucose during normal pregnancy. J Obstet Gynaecol Br Commonw 1972;79:961–5. 137. Corcoy R, Gascon N, De Leiva A, Ordonez LJ. Usual delay in sample processing can modify gestational diabetes screening. Diabetes Care 2000;23:429. 138. Lind T. Antenatal screening using random blood glucose values. Diabetes 1985;34:17–20. 139. Nielsen IK, Vinther S, Birch K, Lange AP. Random blood glucose sampling as an early antenatal screening test for diabetes mellitus. Diabetes Res 1988;8:31–3. 140. Jowett NI, Samanta AK, Burden AC. Screening for diabetes in pregnancy: is a random blood glucose enough? Diabet Med 1987;4:160–3. 141. McElduff A, Goldring J, Gordon P, Wyndham L. A direct comparison of the measurement of a random plasma glucose and a post-50 g glucose load glucose in the detection of gestational diabetes. Aust N Z J Obstet Gynaecol 1994;34:28–30. 142. Agarwal MM, Hughes PF, Ezimokhai M. Screening for gestational diabetes in a high-risk population using fasting plasma glucose. Int J Gynecol Obstet 2000;68:147. 143. Reichelt AJ, Spichler ER, Branchtein L, Nucci LB, Franco LJ, Schmidt MI. Fasting plasma glucose is a useful test for the detection of gestational diabetes. Brazilian Study of Gestational Diabetes (EBDG) Working Group. Diabetes Care 1998;21:1246–9. 144. Jones GC, Walker JD. Poor sensitivity of fasting blood glucose as a screening test for gestational diabetes mellitus and impaired glucose tolerance of pregnancy. Diabet Med 1996;13 Suppl 7:S40. 145. Sacks DA, Greenspoon JS, Fotheringham N. Could the fasting plasma glucose assay be used to screen for gestational diabetes? J Reprod Med Obstet Gynecol 1992;37:907–9. 146. Yalcin HR, Zorlu CG. Threshold value of glucose screening tests in pregnancy: could it be standardized for every population? Am J Perinatol 1996;13:317–20. 147. Danilenko-Dixon DR, Van Winter JT, Nelson RL, Ogburn PL. Universal versus selective gestational diabetes screening: application of 1997 American Diabetes Association recommendations. Am J Obstet Gynecol 1999;181:798–802. 148. Lavin J. Screening of high-risk and general populations for gestational diabetes. Clinical application and cost analysis. Diabetes 1985;34:24–7. 149. Meriggi E, Trossarelli GF, Carta Q, Menato G, Porta MA, Bordon R, et al. Capillary glucose determination in the screening of gestational diabetes. Diabetes Res Clin Pract 1988;5:55–61. 150. Metzger BE, the Organizing Committee. Summary and recommendations of the Third International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes 1991;40 Suppl 2:197–201. 151. Berkus MD, Stern MP, Mitchell BD, Abashawl A, Langer O. Relationships between glucose levels and insulin secretion during a glucose challenge test. Am J Obstet Gynecol 1990;163:1818–22. 152. Lewis GF, McNally C, Blackman JD, Polonsky KS, Barron WM. Prior feeding alters the response to the 50-g glucose challenge test in pregnancy: the Staub–Traugott effect revisited. Diabetes Care 1993;16:1551–6. 153. Cetin M, Cetin A. Time-dependent gestational diabetes screening values. Int J Gynecol Obstet 1997;56:257–61. 154. Kirkpatrick C, Schwers J, Desir D. Prenatal screening for gestational diabetes throughout office hours. Eur J Obstet Gynecol Reprod Biol 1988;27:299–306. 155. Watson WJ. Serial changes in the 50-g oral glucose test in pregnancy: implications for screening. Obstet Gynecol 1989;74:40–3. 156. Jovanovic L, Peterson CM. Screening for gestational diabetes. Optimum timing and criteria for retesting. Diabetes 1985;34:21–3. 157. Nahum GG, Huffaker BJ. Correlation between firstand early third-trimester glucose screening test results. Obstet Gynecol 1990;76:709–13. 158. Benjamin F, Wilson SJ, Deutsch S, Seltzer VL, Droesch K, Droesch J. Effect of advancing pregnancy on the glucose tolerance test and on the 50-g oral glucose load screening test for gestational diabetes. Obstet Gynecol 1986;68:362–5. 159. Super DM, Edelberg SC, Philipson EH, Hertz RH, Kalhan SC. Diagnosis of gestational diabetes in early pregnancy. Diabetes Care 1991;14:288–94. 160. Meyer WJ, Carbone J, Gauthier DW, Gottmann DA. Early gestational glucose screening and gestational diabetes. J Reprod Med Obstet Gynecol 1996;41:675–9. 161. Shivvers SA, Lucas MJ. Gestational diabetes: is a 50-g screening result ≤ 200 mg/dL diagnostic? J Reprod Med Obstet Gynecol 1999;44:685–8. 162. Menon U, Ranjan M, Jasper P, Oommen A. Evaluation of plasma fructosamine as a screening test for gestational diabetes. Aust N Z J Obstet Gynaecol 1991;31:25–6. 163. Kerbel D, Glazier R, Holzapfel S, Yeung M, Lofsky S. Adverse effects of screening for gestational diabetes: a prospective cohort study in Toronto, Canada. J Med Screen 1997;4:128–32. 164. Jirapinyo M, Puavilai G, Chanprasertyotin S, Tangtrakul S. Predictive value of 1 hour 50 g oral glucose load screening test for gestational diabetes mellitus compared to 3 hour oral glucose tolerance test in high risk pregnant women. Asia Oceania J Obstet Gynaecol 1993;19:7–12. 165. Neilson J, Bolton RN, Prins RP, Mark C. Glucose challenge testing in pregnancy. Am J Obstet Gynecol 1991;164:1673–9. 166. Sacks DA, Abu FS, Greenspoon JS, Fotheringham N. How reliable is the fifty-gram, one-hour glucose screening test? Am J Obstet Gynecol 1989;161:642–5. 167. Weiner CP, Fraser MM, Burns JM, Schnoor D, Herrig J, Whitaker LA. Cost efficacy of routine screening for diabetes in pregnancy: 1-h versus 2-h specimen. Diabetes Care 1986;9:255–9. 168. Bergus GR, Murphy NJ. Screening for gestational diabetes mellitus: comparison of a glucose polymer and a glucose monomer test beverage. J Am Board Fam Pract 1992;5:241–7. 169. Lamar ME, Kuehl TJ, Cooney AT, Gayle LJ, Holleman S, Allen SR. Jelly beans as an alternative to a fifty-gram glucose beverage for gestational diabetes screening. Am J Obstet Gynecol 1999;181:1154–7. 170. Coustan DR, Widnes JA, Carpenter MW, Rotondo L, Pratt DC. The ‘breakfast tolerance test’: screening for gestational diabetes with a standardized mixed nutrient meal. Am J Obstet Gynecol 1987;157:1113–17. 171. Vermes I, Zeyen LJJM, Van Roon E, Brandts H. The role of serum fructosamine as a screening test for gestational diabetes mellitus. Horm Metab Res 1989;21:73–6. 172. Nasrat HA, Ajabnoor MA, Ardawi MSM. Fructosamine as a screening test for gestational diabetes mellitus: a reappraisal. Int J Gynecol Obstet 1991;34:27–33. 173. Hughes PF, Agarwal M, Newman P, Morrison J. An evaluation of fructosamine estimation in screening for gestational diabetes mellitus. Diabet Med 1995;12:708–12. 174. Bor MV, Bor P, Cevik C. Serum fructosamine and fructosamine-albumin ratio as screening tests for gestational diabetes mellitus. Arch Gynecol Obstet 1999;262:105–11. 175. Grandjean H, Sarramon MF, De Mouzon J, Reme JM, Pontonnier G. Detection of gestational diabetes by means of ultrasonic diagnosis of excessive fetal growth. Am J Obstet Gynecol 1980;138:790–2. 176. Griffin ME, Coffey M, Johnson H, Scanlon P, Foley M, Stronge J, et al. Universal vs. risk factorbased screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome. Diabet Med 2000;17:26–32. 177. Dietrich ML, Dolnicek TF, Rayburn WF. Gestational diabetes screening in a private, midwestern American population. Am J Obstet Gynecol 1987;156:1403–8. 178. Rust O, Bofill JA, Carroll SC, Cowan BD, Martin RW, Morrison JC. Two-hour postprandial test versus one-hour, fifty-gram glucola test as screening tools for gestational diabetes: a critical analysis. J Perinatol 1998;18:49–54. 179. Bevier WC, Fischer R, Jovanovic L. Treatment of women with an abnormal glucose challenge test (but a normal oral glucose tolerance test) decreases the prevalence of macrosomia. Am J Perinatol 1999;16:269–75. 180. Bebbington MW, Milner R, Wilson RD, Harris S. A randomized controlled trial comparing routine screening vs. selected screening for gestational diabetes in low risk population. Am J Obstet Gynecol 1999;180:S36. 181. Casey BM, Lucas MJ, McIntire DD, Leveno KJ. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population [see comments]. Obstet Gynecol 1997;90:869–73. 182. Uncu G, Ozan H, Cengiz C. The comparison of 50 grams glucose challenge test, HbA1c and fructosamine levels in diagnosis of gestational diabetes mellitus. Clin Exp Obstet Gynecol 1995;22:230–4. 183. Corcoy R, Cerqueira MJ, Pedreno J, Matas J, Codina M, Pou JM, et al. Serum fructosamine is not a useful screening test for gestational diabetes. Eur J Obstet Gynecol Reprod Biol 1991;38:217–20. 184. Mathai M, Thomas TJ, Kuruvila S, Jairaj P. Random plasma glucose and the glucose challenge test in pregnancy. Natl Med J India 1994;7:160–2. 185. Fuhrmann K. Targets in oral glucose tolerance. In: Sutherland HW, Stowers JM, Pearson DWM, editors. Carbohydrate metabolism in pregnancy and the newborn. London: Springer-Verlag; 1989. p. 227–37. 186. Tam WH, Rogers MS, Yip SK, Lau TK, Leung TY. Which screening test is the best for gestational impaired glucose tolerance and gestational diabetes mellitus? Diabetes Care 2000;23:1432. 187. Reece EA, Holford T, Tuck S, Bargar M, O’Connor T, Hobbins JC. Screening for gestational diabetes: one-hour carbohydrate tolerance test performed by a virtually tasteless polymer of glucose. Am J Obstet Gynecol 1987;156:132–4. 188. Murphy NJ, Meyer BA, O’Kell RT, Hogard ME. Carbohydrate sources for gestational diabetes mellitus screening. A comparison. J Reprod Med 1994;39:977–81. 189. Zhang Y, Warren PM, Sakura H, Adelman J, Stoffel M, Bell GI, et al. No evidence for mutations in a putative beta-cell ATP-sensitive K(+) channel subunit in MODY, NIDDM, or GDM. Diabetes 1995;44:597–600. 190. Bloomgarden ZT. American Diabetes Association 60th Scientific Sessions, 2000. Diabetes Care 2000;23:1699–702. 191. Swinker M. Routine screening for gestational diabetes mellitus in a family practice center. J Fam Pract 1983;17:611–14. 192. Lemen PM, Wigton TR, Miller-McCarthey AJ, Cruikshank DP, Hiss LW, Van Winter J, et al. Screening for gestational diabetes mellitus in adolescent pregnancies. Am J Obstet Gynecol 1998;178:1251–6. 193. Netten A, Curtis L, compilers. Unit costs of health and social care 2000. Canterbury: University of Kent, Personal Social Services Research Unit (PSSRU), 2000. 194. MIMS. Monthly Index of Medical Specialities. Haymarket Medical Ltd. 29-1-0001. URL: http://www.emims.net 195. Berwick DM, Weinstein MC. What do patients value? Willingness to pay for ultrasound in normal pregnancy. Med Care 1985;23:881–93. 196. Mooney G. The valuation of human life. London: Macmillan; 1977. 197. Comtois R, Desjarlais F, Nguyen M, Beauregard H. Clinical usefulness of estimation of serum fructosamine concentration as screening test for gestational diabetes. Am J Obstet Gynecol 1989;160:651–4. 198. Office of National Statistics. Health Statistics Quarterly. 8. London: ONS; 2000. 199. Maresh M, Beard RW, Bray CS, Elkeles RS, Wadsworth J. Factors predisposing to and outcome of gestational diabetes. Obstet Gynecol 1989;74:342–6. 200. Cousins L, Baxi L, Chez R, Coustan DR, Gabbe S, Harris J, et al. Screening recommendations for gestational diabetes mellitus. Am J Obstet Gynecol 1991;165:493–6. 201. Howard ED. Gestational diabetes mellitus screening tests: a review of current recommendations. J Neonatal Nurs 1992;6:37–42. 202. Damm P, Kuhl C, Bertelsen A, Molsted-Pederson L. Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol 1992;167:607–16. 203. Blank A, Metzger BE, Grave GD. Effects of gestational diabetes on perinatal morbidity reassessed: report of the International Workshop on Adverse Perinatal Outcomes of Gestational Diabetes Mellitus. Diabetes Care 1995;18:127–9. 204. Rossi M, Dornhorst A. Diabetes following gestational diabetes mellitus. In: Dornhorst A, Hadden D, editors. Diabetes and pregnancy: an international approach to diagnosis and management. Chichester: John Wiley & Sons; 1996. 205. Currie CJ, Kraus D, Morgan CL, Gill L, Stott NC, Peters JR. NHS acute sector expenditure for diabetes. Diabet Med 1997;14:686–92. 206. Grant PT, Oats JN, Beischer NA. The long term follow up of women with gestational diabetes. Aust N Z J Obstet Gynaecol 1986;26:17–22. 207. Kjos SL, Peters RK, Henry OA, Montoro MN, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes. Diabetes 1995;44:586–91. 208. O’Sullivan JB. Diabetes mellitus after GDM. Diabetes 1991;29:131–5. 209. Coustan DR. Management of gestational diabetes mellitus. JAMA 1996;275:1199–200. 210. Jovanovic-Peterson L, Peterson CM. Is exercise safe or useful for gestational diabetic women? Diabetes 1991;40:179–81. 211. Homko CJ, Reece EA. To screen or not to screen for gestational diabetes mellitus. The clinical quagmire. Clin Perinatol 2001;28:407–17. 212. de Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995;353:1237–41. 213. Lauszus FF, Paludan J, Kebe JG. Birthweight in women with potential gestational diabetes mellitus – an effect of obesity rather than glucose intolerance? Acta Obstet Gynecol Scand 1999;78:520–5. 214. Lind T, Anderson J. Does random blood glucose sampling outdate testing for glycosuria in the detection of diabetes during pregnancy? BMJ 1984;289:1569–71. 215. Benjamin E, Winters D, Mayfield J, Gohdes D. Diabetes in pregnancy in Zuni Indian women. Prevalence and subsequent development of clinical diabetes after gestational diabetes. Diabetes Care 1993;16:1231–5. 216. American Diabetes Association. Summary and recommendations of the Third International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes 1985;40 Suppl 2:123–6. 217. Begley JP, Stafford KA, Clark JDA. Fructosamine as a screening test for diabetes mellitus. Pract Diabetes 1992;9:104–5. 218. Huter O, Drexel H, Brezinka C, Soelder E, Koelle D, Patsch JR. Low sensitivity of serum fructosamine as a screening parameter for gestational diabetes mellitus. Gynecol Obstet Invest 1992;34:20–3. 219. Al-Shawaf T, Moghraby S, Akiel A. Does impaired glucose tolerance imply a risk in pregnancy? Br J Obstet Gynaecol 1988;95:1036–41. 220. Ammari F, Gregory R. Screening for gestational diabetes in a population at high risk. Pract Diabetes Int 1996;13:150–2. 221. Ardawi MSM, Nasrat HA, Jamal HS, Al Sagaaf HM, Mustafa BE. Screening for gestational diabetes mellitus in pregnant females. Saudi Med J 2000;21:155–60. 222. Artal R, Mosley GM, Dorey FJ. Glycohemoglobin as a screening test for gestational diabetes. Am J Obstet Gynecol 1984;148:412–14. 223. Bartha JL, Martinez DF, Comino DR. Gestational diabetes mellitus diagnosed during early pregnancy. Am J Obstet Gynecol 2000;182:346–50. 224. Baxi L, Barad D, Reece EA, Farber R. Use of glycosylated hemoglobin as a screen for macrosomia in gestational diabetes. Obstet Gynecol 1984;64:347–50. 225. Berkus MD, Langer O. Glucose tolerance test: degree of glucose abnormality correlates with neonatal outcome. Obstet Gynecol 1993;81:344–8. 226. Campbell DM, Sutherland HW, Tuttle S. Standardized test meal in human pregnancy. In: Sutherland HW, Stowers JM, Pearson DWM, eds. Carbohydrate metabolism in pregnancy and the newborn IV. London: Springer-Verlag; 1989. p. 257–65. 227. Cooper A, Granat M, Sharf M. Glucose intolerance during pregnancy. II. A comparative study of diagnostic screening methods. Obstet Gynecol 1979;53:495–9. 228. Di Cianni G, Benzi L, Casadidio I, Orsini P, Rossi L, Fontana G, et al. Screening of gestational diabetes in Tuscany: results in 2000 cases. Ann 1st Super Sanita 1997;33:389–91. 229. de los Monteros AE, Parra A, Ramirez A. The reproducibility of the 50 g 1-hour glucose screen for diabetes in pregnancy. Obstet Gynecol 1993;82:515–18. 230. Gillmer MD, Bickerton NJ. Advances in the management of diabetes in pregnancy: success through simplicity. In: Bonnar J, editor. Recent advances in obstetrics and gynaecology. Edinburgh: Churchill Livingstone: 1994. 231. Dornhorst A, Nicholls JSD, Welch A, Ali K, Chan SP, Beard RW. Correcting for ethnicity when defining large for gestational age infants in diabetic pregnancies. Diabetic Med 1996;13:226–31. 232. Fedele D, Lapolla A. A protocol of screening of gestational diabetes mellitus. Ann 1st Super Sanita 1997;33:383–7. 233. Forest JC, Masse J, Garrido RM. Glucose tolerance test during pregnancy: the significance of one abnormal value. Clin Biochem 1994;27:299–304. 234. Greenberg LR, Moore TR, Murphy H. Gestational diabetes mellitus: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol 1995;86:97–101. 235. Gregory R, Swinn RA, Wareham N, Curling V, Dalton KJ, Edwards OM, et al. An audit of a comprehensive screening programme for diabetes in pregnancy. Pract Diabetes Int 1998;15:45–8. 236. Hadden D. Evidence-based screening for gestational diabetes? Diabet Med 2000;17:402. 237. Hughes PF, Agarwal M, Newman P, Morrison J. Screening for gestational diabetes in a multi-ethnic population. Diabetes Res Clin Pract 1995;28:73–8. 238. Knopp RH, Magee MS, Walden CE, Bonet B, Benedetti TJ. Prediction of infant birth-weight by GDM screening tests – importance of plasma triglyceride. Diabetes Care 1992;15:1605–13. 239. Landon MB, Gabbe SG, Sachs L. Management of diabetes mellitus and pregnancy: a survey of obstetricians and maternal-fetal specialists. Obstet Gynecol 1990;75:635–40. 240. Lavin JP, Barden TP, Miodovnik M. Clinical experience with a screening program for gestational diabetes. Am J Obstet Gynecol 1981;141:491–4. 241. Lind T, Phillips PR. Influence of pregnancy on the 75-g OGTT: a prospective multicenter study. Diabetes 1991;40:8–13. 242. Lindsay MK, Graves W, Klein L. The relationship of one abnormal glucose tolerance test value and pregnancy complications. Obstet Gynecol 1989;73:103–6. 243. Merkatz IR, Duchon MA, Yamashita TS, Houser HB. A pilot community-based screening program for gestational diabetes. Diabetes Care 1980;3:453–7. 244. Moses RG, Fulwood S, Griffiths BN, Griffiths R. Gestational diabetes mellitus: resource utilization and costs of diagnosis and treatment. Aust N Z J Obstet Gynaecol 1997;37:184–6. 245. Narchi H, Kulaylat N. High incidence of Down’s syndrome in infants of diabetic mothers. Arch Dis Child 1997;77:242–4. 246. Rajab KE, Mehdi S. Pregnancy outcome among gestational diabetics with blood glucose levels between 7.7 and 8.3 mmol/l. Int J Gynaecol Obstet 1998;63:59–61. 247. Rey E. Usefulness of a breakfast test in the management of women with gestational diabetes. Obstet Gynecol 1997;89:981–8. 248. Rust OA, Bofill JA, Andrew ME, Kincaid TA, Stubbs TM, Miller EH, et al. Lowering the threshold for the diagnosis of gestational diabetes. Am J Obstet Gynecol 1996;175:961–5. 249. Shah BD, Cohen AW, May C, Gabbe SG. Comparison of glycohemoglobin determination and the one-hour oral glucose screen in the identification of gestational diabetes. Am J Obstet Gynecol 1982;144:774–7. 250. Solomon CG, Willett WC, Rich EJ, Hunter DJ, Stampfer MJ, Colditz GA, et al. Variability in diagnostic evaluation and criteria for gestational diabetes. Diabetes Care 1996;19:12–16. 251. Solomon CG, Willett WC, Carey VJ, Rich EJ, Hunter DJ, Colditz GA, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997;278:1078–83. 252. Thaisz E, Rappai A, Fovenyi J, Zavodi E. Screening and care of gestational and insulin-dependent diabetic pregnancies: the first four years’ experience. Diabetes Nutr Metab Clin Exp 1993;6:373–5. 253. Van Turnhout HEW, Lotgering FK, Wallenburg HCS. Poor sensitivity of the fifty-gram one-hour glucose screening test for hyperglycemia. Eur J Obstet Gynecol Reprod Biol 1994;53:7–10. 254. Verma A, Mitchell BF, Demianczuk N, Flowerdew G, Okun NB. Relationship between plasma glucose levels in glucose-intolerant women and newborn macrosomia. J Matern Fetal Med 1997;6:187–93. 255. Williams CB, Iqbal S, Zawacki CM, Yu D, Brown MB, Herman WH. Effect of selective screening for gestational diabetes. Diabetes Care 1999;22:418–21. 256. Young C, Kuehl TJ, Sulak PJ, Allen SR. Gestational diabetes screening in subsequent pregnancies of previously healthy patients. Am J Obstet Gynecol 2000;182:1024.
URI:	http://wrap.warwick.ac.uk/id/eprint/52148

Request changes to a record

Actions (login required)

View Item